Ayrle Hannah, Mevissen Meike, Kaske Martin, Nathues Heiko, Gruetzner Niels, Melzig Matthias, Walkenhorst Michael
Department of Livestock Sciences, Research Institute of Organic Agriculture (FiBL), Ackerstrasse 113, postbox 219, Frick, 5070, Switzerland.
Division Veterinary Pharmacology & Toxicology, Department Clinical Research and Veterinary Public Health, Vetsuisse Faculty, University of Bern, Laenggassstrasse 124, Bern, 3012, Switzerland.
BMC Vet Res. 2016 Jun 6;12:89. doi: 10.1186/s12917-016-0714-8.
Gastrointestinal and respiratory diseases in calves and piglets lead to significant economic losses in livestock husbandry. A high morbidity has been reported for diarrhea (calves ≤ 35%; piglets ≤ 50%) and for respiratory diseases (calves ≤ 80%; piglets ≤ 40%). Despite a highly diverse etiology and pathophysiology of these diseases, treatment with antimicrobials is often the first-line therapy. Multi-antimicrobial resistance in pathogens results in international accordance to strengthen the research in novel treatment options. Medicinal plants bear a potential as alternative or additional treatment. Based on the versatile effects of their plant specific multi-component-compositions, medicinal plants can potentially act as 'multi-target drugs'. Regarding the plurality of medicinal plants, the aim of this systematic review was to identify potential medicinal plant species for prevention and treatment of gastrointestinal and respiratory diseases and for modulation of the immune system and inflammation in calves and piglets.
Based on nine initial sources including standard textbooks and European ethnoveterinary studies, a total of 223 medicinal plant species related to the treatment of gastrointestinal and respiratory diseases was identified. A defined search strategy was established using the PRISMA statement to evaluate 30 medicinal plant species starting from 20'000 peer-reviewed articles published in the last 20 years (1994-2014). This strategy led to 418 references (257 in vitro, 84 in vivo and 77 clinical trials, thereof 48 clinical trials in veterinary medicine) to evaluate effects of medicinal plants and their efficacy in detail. The findings indicate that the most promising candidates for gastrointestinal diseases are Allium sativum L., Mentha x piperita L. and Salvia officinalis L.; for diseases of the respiratory tract Echinacea purpurea (L.) MOENCH, Thymus vulgaris L. and Althea officinalis L. were found most promising, and Echinacea purpurea (L.) MOENCH, Camellia sinensis (L.) KUNTZE, Glycyrrhiza glabra L. and Origanum vulgare L. were identified as best candidates for modulation of the immune system and inflammation.
Several medicinal plants bear a potential for novel treatment strategies for young livestock. There is a need for further research focused on gastrointestinal and respiratory diseases in calves and piglets, and the findings of this review provide a basis on plant selection for future studies.
犊牛和仔猪的胃肠道及呼吸道疾病给畜牧业造成了重大经济损失。腹泻(犊牛≤35%;仔猪≤50%)和呼吸道疾病(犊牛≤80%;仔猪≤40%)的发病率较高。尽管这些疾病的病因和病理生理学高度多样,但抗菌药物治疗往往是一线治疗方法。病原体中的多重耐药性促使国际上加强对新型治疗方案的研究。药用植物具有作为替代或辅助治疗的潜力。基于其植物特有的多成分组合的多种作用,药用植物有可能充当“多靶点药物”。鉴于药用植物种类繁多,本系统评价的目的是确定预防和治疗犊牛及仔猪胃肠道和呼吸道疾病以及调节其免疫系统和炎症的潜在药用植物种类。
基于包括标准教科书和欧洲民族兽医学研究在内的9个初始来源,共鉴定出223种与胃肠道和呼吸道疾病治疗相关的药用植物。使用PRISMA声明建立了明确的检索策略,以从过去20年(1994 - 2014年)发表的20000篇同行评议文章中评估30种药用植物。该策略产生了418篇参考文献(257篇体外研究、84篇体内研究和77篇临床试验,其中48篇为兽医学临床试验),以详细评估药用植物的作用及其疗效。研究结果表明,对胃肠道疾病最有前景的候选植物是大蒜(Allium sativum L.)、薄荷(Mentha x piperita L.)和鼠尾草(Salvia officinalis L.);对呼吸道疾病而言,紫锥菊(Echinacea purpurea (L.) MOENCH)、百里香(Thymus vulgaris L.)和药蜀葵(Althea officinalis L.)最具前景,而紫锥菊(Echinacea purpurea (L.) MOENCH)、茶树(Camellia sinensis (L.) KUNTZE)、甘草(Glycyrrhiza glabra L.)和牛至(Origanum vulgare L.)被确定为调节免疫系统和炎症的最佳候选植物。
几种药用植物具有用于幼畜新型治疗策略的潜力。需要针对犊牛和仔猪的胃肠道及呼吸道疾病开展进一步研究,本综述的结果为未来研究的植物选择提供了依据。